You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華潤醫療(01515.HK):法院維持「燕化IOT協議」判決 獲支付1,440萬人幣違約金
阿思達克 11-24 08:58
華潤醫療(01515.HK)公布,就起訴燕化鳳凰及燕化醫院自2019年1月21日起解除與公司附屬「華潤醫管」的「燕化IOT協議」,北京市高級人民法院於星期一(22日)駁回上述燕化鳳凰和燕化醫院的上訴,維持2019年12月18日的原判決,並裁定此為終審判決。 於2019年12月18日,北京市第二中級人民法院宣告燕化鳳凰及燕化醫院對燕化IOT協議作出的解除為無效,因此協議方應繼續履行燕化IOT協議,燕化鳳凰須向華潤醫管支付金額為1,440萬元人民幣之違約金。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account